Midcaps have mobilize while blue chips underperformed sharply, & investors who chose midcaps have made double the returns when compared with that of large caps. The run-up has led to some midcap stocks being overvalued, financial advisors & fund managers said that investors should now turn to large caps.
Some distrust toward blue chips arose after the Dow Jones took a major hit in the massive volatility swings. Many health companies continue to hover toward the bottom of their 52-week range in spite of being a safer bet than the treasury's many investors are chasing.